GlassScriptPhysician profile
George Ibrahim Soliman
NPI 1396189858
$16,917.79
in general payments reported to CMS, 2019-2025
46 companies · $1,452 in 2025
The $1,452 reported for 2025 was more than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,367 · 2020: $790 · 2021: $1,033 · 2022: $1,554 · 2023: $7,304 · 2024: $2,419 · 2025: $1,452.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,305 · Travel and Lodging: $3,870.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,304.58 |
| Travel and Lodging | $3,869.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,616.66 | 2019-2025 | Superion Indirect Decompression System, Intracept, General - Pain Management |
| Abbvie INC. | $2,090.89 | 2021-2025 | Botox, Ubrelvy, Qulipta |
| Abbott Laboratories | $1,947.98 | 2019-2025 | Proclaim, Eterna |
| Stryker Corporation | $1,928.52 | 2019-2025 | Spinejack, Autoplex, Optablate |
| Relievant Medsystems, INC. | $1,412.18 | 2023 | Intracept |
| Nevro Corp. | $1,004.97 | 2019-2024 | Senza |
| Amgen INC. | $772.52 | 2019-2022 | |
| Medtronic, INC. | $597.83 | 2022-2025 | Intellis Adaptivestim, Vanta Adaptivestim, Inceptiv |
| Scilex Pharmaceuticals INC. | $483.14 | 2020-2023 | Ztlido |
| Collegium Pharmaceutical, INC. | $315.12 | 2019-2025 | Belbuca |
| Allergan, INC. | $248.46 | 2019-2022 | |
| Spinal Simplicity, LLC | $222.27 | 2023-2025 | Ha Minuteman G3-R |
| Pfizer INC. | $218.40 | 2023-2025 | |
| Biodelivery Sciences International, INC. | $209.24 | 2019-2021 | |
| Globus Medical, INC. | $198.82 | 2025 | Senza |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Soliman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.